Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AGA Medical Corporation
AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder
January 23rd, 2009
AGA Medical Corporation ("AGA Medical") announced that it received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its AMPLATZER(R) Duct Occluder (ADO). The ADO is a percutaneous, transcatheter occlusion device used for the non-surgical closure of patent ductus arteriosus (PDA), a common type of congenital heart defect that occurs when a blood vessel known as the ductus arteriosus fails to close after birth, as it normally should. "We are very pleased to achieve this regulatory and commercial milestone in Japan," said John Barr, President and CEO of AGA Medical. "Our exclusive distribution partner, Japan Lifeline Co., Ltd., will immediately...
Source: Health Business Week (2009-01-23)
|
